top of page

Glioblastoma Multiforme

Sowmya Shivarama

Content writer – Clinical

August 19, 2022

Summary "Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells."

Glioblastoma multiforme (GBM), the most aggressive brain cancer, recurs due to the resistance of glioblastoma stem cells (GSCs) to all standard therapies. This dismal therapy outcome has sparked intense...

Glioblastoma Multiforme
Numair Arshad

Content writer – Clinical

August 05, 2022

Summary "Slowing down glioma growth by knocking out miR-21 in mice models."

Glioblastoma multiforme (GBM) is an aggressive form of glioma with a median survival of 15 months. Heterogeneity is one of the main characteristics of GBM. The tumor cells show variability not only from one patient...

Glioblastoma Multiforme

Content writer – Clinical

July 29, 2022

Summary "Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma."

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain cancer in adults. It accounts for about 60-70% of gliomas. The standard treatment regimen for GBM is tumor resection followed...

Glioblastoma Multiforme
Swetha Chakrabarthi

Jr. scientist – Omics

July 15, 2022

Summary "Multifunctional silica-coated mixed polymeric micelles for integrin-targeted therapy of pediatric patient-derived glioblastoma."

Glioblastoma (GBM) is the malignant brain tumor of the primary central nervous system (CNS) arising from the glial cells having an incidence ranging from 5 to 8 persons per 100,000 individuals...

Glioblastoma Multiforme
Vijay Padul

Sr. scientist - Omics

June 29, 2022

Summary "A phase Ib-IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma- CUSP9v3-2021."

Glioblastoma is the most common and aggressive primary malignant brain tumor in adults. Despite therapeutic interventions, glioblastoma prognosis remains very poor as most patients die…

Glioblastoma Multiforme
Nupur Biswas

Sr. scientist – Omics

June 24, 2022

Summary "Identification of new genetic clusters in glioblastoma multiforme: EGFR status and ADD3 losses influence prognosis."

Glioblastoma (GB) multiforme, IDH wild-type (GB-IDHwt) is the most frequent brain tumor with poor survival rate. Glioblastoma with mutant IDH enzyme shows good prognosis. The highly genetic heterogeity is responsible…

Glioblastoma Multiforme
Souvik Datta

Content writer – Clinical

June 16, 2022

Summary "Effects of metformin as an add-on therapy against glioblastoma: an old medicine for novel oncology therapeutics."

Medical research is focused on finding solutions through diligent and innovative platforms in the field of health and disease. Every published paper holds a stepping stone toward gaining knowledge…

Glioblastoma Multiforme
Connecting Dots

Get the latest updates

Join Cell talk!

Subscribe us today & receive latest updates on your mail !

bottom of page